Gelonghui, April 22 | China Tongzhu (01763.HK) announced that recently, the first domestic-produced Wanjuli grade carrier-free -177 GMP production line, with an annual production capacity of 1,000 germanium gallium 68Ge-68Ga generators, has been fully completed and put into operation, marking the actual realization of the large-scale commercial supply of GMP-grade GMP-grade GE-177 and Gallium-68 medical nuclides. The smooth commissioning of the production line will effectively mitigate the problem of insufficient domestic supply of Zn-177 and Gallium-68, which is heavily dependent on imports.
The two products of Chengdu CNNC Qualcomm Isotope Co., Ltd. (“CNNC Qualcomm”), a subsidiary of the company, meet EMA standards requirements in terms of production line design, production technology, quality indicators, equipment and facilities, management systems, etc., and are in the first tier of the world, and have a clear international competitive advantage. Subsequently, CNNC Qualcomm will enter the international market and participate in the major cycle of the international medical nuclide industry chain.
At the same time, CNNC Qualcomm can also officially supply Curie-grade terbium-161 and scandium-47, which have similar decay, biochemical properties, and in-vivo properties. They also have unique advantages, which will bring new opportunities and possibilities for the development of nuclear medicine.